Freedom Biosciences

Freedom Biosciences is a clinical-stage biotech platform company developing next-generation ketamine and psychedelic therapeutics.

Freedom Biosciences

 Freedom has developed a biotech platform designed to address the biggest shortcoming of first-generation psychedelics. The company’s platform specializes in novel ketamine formulations, enabling medical professionals to treat patients with treatment-resistant depression.

The company was co-founded by Dina Burkitbayeva who is also a co-founder and partner at PsyMed Ventures.

Company Information

Freedom Biosciences Website

January, 1970


B2B B2C Biotech

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships


HQ / Office United States